Literature DB >> 15950182

Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53.

Hui Jia Chan1, Jing Jei Weng, Benjamin Yat Ming Yung.   

Abstract

The Rev peptide that binds to nucleophosmin/B23 with the highest affinity exhibited the greatest cytotoxicity on Ras-3T3 cells and inhibited tumor growth most effectively in nude mice. The efficiency of colony formation in soft agar of Ras-3T3 cells was significantly inhibited by treatment with Rev peptide. In addition, Rev peptide could potentiate the doxorubicin-induced decrease of cellular viability in U1 bladder cancer cells and inhibition of tumor growth in nude mice. Treatment of Rev peptide increased protein expression and transcriptional activity of p53 and inhibited the nucleophosmin/B23-mediated PCNA promoter activation. Peptides having high affinity of binding to molecular targets such as nucleophosmin/B23 represent a potentially useful approach to anti-cancer biotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950182     DOI: 10.1016/j.bbrc.2005.04.176

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.

Authors:  Ruth A Gjerset
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 2.611

2.  Nucleophosmin is selectively deposited on mRNA during polyadenylation.

Authors:  Viswanathan Palaniswamy; Karen C M Moraes; Carol J Wilusz; Jeffrey Wilusz
Journal:  Nat Struct Mol Biol       Date:  2006-04-09       Impact factor: 15.369

3.  The natural product avrainvillamide binds to the oncoprotein nucleophosmin.

Authors:  Jeremy E Wulff; Romain Siegrist; Andrew G Myers
Journal:  J Am Chem Soc       Date:  2007-10-25       Impact factor: 15.419

4.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

5.  Inhibition of nucleophosmin 1 suppresses colorectal cancer tumor growth of patient -derived xenografts via activation of p53 and inhibition of AKT.

Authors:  Angel C Y Yu; Yi-Jye Chern; Peter Zhang; Clarissa C Pasiliao; Mahbuba Rahman; George Chang; Jianhua Ren; Isabella T Tai
Journal:  Cancer Biol Ther       Date:  2021-01-15       Impact factor: 4.742

6.  Dephosphorylation of nucleophosmin by PP1β facilitates pRB binding and consequent E2F1-dependent DNA repair.

Authors:  Chiao Yun Lin; Bertrand Chin-Ming Tan; Hsuan Liu; Chii-Jiun Shih; Kun-Yi Chien; Chih-Li Lin; Benjamin Yat-Ming Yung
Journal:  Mol Biol Cell       Date:  2010-10-20       Impact factor: 4.138

Review 7.  Molecules that target nucleophosmin for cancer treatment: an update.

Authors:  Adele Di Matteo; Mimma Franceschini; Sara Chiarella; Serena Rocchio; Carlo Travaglini-Allocatelli; Luca Federici
Journal:  Oncotarget       Date:  2016-07-12

8.  Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway.

Authors:  Yingsheng Xiao; Jianling Zhu; Chunyan Peng; Weiquan Liang; Haoyu Lin
Journal:  Cancer Manag Res       Date:  2018-12-21       Impact factor: 3.989

9.  Elucidation of motifs in ribosomal protein S9 that mediate its nucleolar localization and binding to NPM1/nucleophosmin.

Authors:  Mikael S Lindström
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.